Stay updated on Eteplirsen in DMD Patients Clinical Trial

Sign up to get notified when there's something new on the Eteplirsen in DMD Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eteplirsen in DMD Patients Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the age range of male participants eligible for the study on Duchenne Muscular Dystrophy (DMD) involving the drug eteplirsen. This change may impact the inclusion criteria for the study and potentially broaden the age range of participants.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:04.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that male participants aged 7-16 years old with a confirmed diagnosis of DMD and stable corticosteroid use are eligible. Previously, no specific information was provided in this section.
    Difference
    10%
    Check dated 2024-05-22T21:18:33.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:23.000Z thumbnail image

Stay in the know with updates to Eteplirsen in DMD Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eteplirsen in DMD Patients Clinical Trial page.